{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Beetham T"],"funding":["NIDA NIH HHS","AHRQ HHS","NIAAA NIH HHS"],"pagination":["1122-1130"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12809527"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["44(9)"],"pubmed_abstract":["Starting in 2015, states could access previously restricted Medicaid funds for residential addiction treatment through Medicaid Section 1115 waivers, contingent on new requirements. Using facility-level survey data and a quasi-experimental difference-in-differences framework, we describe changes in Medicaid patients' access to medications for opioid use disorder (MOUD) in residential addiction treatment facilities during the period 2012-22 and assess the role of facility turnover in these outcomes. Four years after the policy took effect, facilities in six intervention states that adopted the waivers were 26 percentage points more likely to accept Medicaid patients and provide MOUD relative to nineteen control states. Most of the increase (89 percent) was driven by differences in facility "],"journal":["Health affairs (Project Hope)"],"pubmed_title":["Medicaid: Increased Patient Access To MOUD In Residential Treatment Associated With Facility Openings And Closures, 2012-22."],"pmcid":["PMC12809527"],"funding_grant_id":["T32 HS017589","R01 DA057789","R36 DA058877","R01 AA030170"],"pubmed_authors":["Newton H","Fiellin DA","Ndumele CD","Beetham T","Busch S"],"additional_accession":[]},"is_claimable":false,"name":"Medicaid: Increased Patient Access To MOUD In Residential Treatment Associated With Facility Openings And Closures, 2012-22.","description":"Starting in 2015, states could access previously restricted Medicaid funds for residential addiction treatment through Medicaid Section 1115 waivers, contingent on new requirements. Using facility-level survey data and a quasi-experimental difference-in-differences framework, we describe changes in Medicaid patients' access to medications for opioid use disorder (MOUD) in residential addiction treatment facilities during the period 2012-22 and assess the role of facility turnover in these outcomes. Four years after the policy took effect, facilities in six intervention states that adopted the waivers were 26 percentage points more likely to accept Medicaid patients and provide MOUD relative to nineteen control states. Most of the increase (89 percent) was driven by differences in facility ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-06-06T16:06:44.756Z","creation":"2026-06-02T03:12:22.657Z"},"accession":"S-EPMC12809527","cross_references":{"pubmed":["40893069"],"doi":["10.1377/hlthaff.2025.00348"]}}